Literature DB >> 7295166

Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines.

C J Krause, T E Carey, R W Ott, C Hurbis, K D McClatchey, J A Regezi.   

Abstract

Squamous cell carcinoma is the most common of human cancers, and yet because it is poorly represented by cultured cell lines, little is known about the characteristic cell biology and the cell-surface antigenic phenotypes of such tumors. To develop a continuously available source of squamous cell carcinoma for repeated and reproducible serologic analysis and for better understanding of its biologic characteristics, tissue culture methods and nude mice were used to establish new cell lines of squamous carcinoma. Special media, serum supplements from several sources, and methods of handling fresh tissue specimens were all examined as a means of improving the survival of tumor cell lines. Several new cell lines were established. Features characteristic of a squamous cell origin, eg, microvilli, desmosomes, tonofilaments, and the squamous cell differentiation antigen (pemphigus antigen), were found. The clinical course of disease in individual donor patients has been examined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295166     DOI: 10.1001/archotol.1981.00790470051012

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  50 in total

1.  UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.

Authors:  Alice L Tang; Samantha J Hauff; John H Owen; Martin P Graham; Michael J Czerwinski; Jung Je Park; Heather Walline; Silvana Papagerakis; Jay Stoerker; Jonathan B McHugh; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2011-12-13       Impact factor: 3.147

2.  Endothelial derived factors inhibit anoikis of head and neck cancer stem cells.

Authors:  Marcia S Campos; Kathleen G Neiva; Kristy A Meyers; Sudha Krishnamurthy; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-10-19       Impact factor: 5.337

3.  Immortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer Research.

Authors:  Joshua D Smith; Andrew C Birkeland; Edward B Goldman; J Chad Brenner; Thomas E Carey; Kayte Spector-Bagdady; Andrew G Shuman
Journal:  J Clin Oncol       Date:  2017-04-20       Impact factor: 44.544

4.  Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.

Authors:  K Pekkola-Heino; M Jaakkola; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Authors:  Andre Cassell; Maria L Freilino; Jessica Lee; Sharon Barr; Lin Wang; Mary C Panahandeh; Sufi M Thomas; Jennifer R Grandis
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

6.  Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.

Authors:  Changyou Li; Rongxiu Li; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

7.  Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck.

Authors:  D R Vlock; B Arnold; J Humpierres; D R Schwartz; S R Baker; C J Krause; N Swanson; T E Carey
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.

Authors:  Lihua Hu; Jingpeng Liu; Zhi Li; Chunling Wang; Ali Nawshad
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-06-08

9.  Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence.

Authors:  Laura C Kelley; Karen E Hayes; Amanda Gatesman Ammer; Karen H Martin; Scott A Weed
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

10.  Systematic validation of predicted microRNAs for cyclin D1.

Authors:  Qiong Jiang; Ming-Guang Feng; Yin-Yuan Mo
Journal:  BMC Cancer       Date:  2009-06-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.